Zhejiang Raybow Pharmaceutical Co., Ltd., Taizhou, China – FDA Inspections

Inspection records and compliance data for Zhejiang Raybow Pharmaceutical Co., Ltd. in Taizhou. 4 FDA inspections on record, 1 Form 483, last inspected November 01, 2024.

Company Profile

This profile covers Zhejiang Raybow Pharmaceutical Co., Ltd. based in Taizhou, China.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 2
NAI: 2
Form 483s: 1
Warning letters: 0

First inspected April 29, 2014. Last inspected November 1, 2024.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
November 1, 2024	NAI	Human Drugs · Drug Quality Assurance	1256688
July 11, 2019	VAI	Human Drugs · Drug Quality Assurance	1096223
April 22, 2016	NAI	Human Drugs · Drug Quality Assurance	976084
April 29, 2014	VAI	Human Drugs · Drug Quality Assurance	878238

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Betta Pharmaceuticals Co., Ltd.-Site C

Lianyungang Runzhong Pharmaceutical Co., Ltd.

Shanghai Haoyuan Chemexpress Co., Ltd.

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.

Yantai Dongcheng Biochemicals Co., Ltd.

Wuzhou Huangpu Chemical Pharmaceutical Co., Ltd.

Hefei Lifeon Pharmaceutical Co., Ltd. (API branch)

Jiangsu Yutian Pharmaceutical Co., Ltd.

Maanshan Cosmos Chemical Co., Ltd.

Shenzhou Jiheng Pharmaceutical Co., Ltd.